By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427



Company News
Amarantus BioSciences Requests Rare Pediatric Disease Designation From US FDA For MANF In The Treatment Of Retinitis Pigmentosa 2/5/2016 6:53:09 AM
Amarantus BioSciences Receives Dual Notices Of Allowance From European Patent Office For Engineered Skin Substitute (ESS) 2/3/2016 7:36:01 AM
Amarantus BioSciences Announces Issuance Of Chinese Patent Covering Use Of MANF For The Treatment Of Parkinson's Disease 1/29/2016 7:28:15 AM
Amarantus BioSciences Announces $1M Investment 1/28/2016 10:40:22 AM
Amarantus BioSciences, Inc. to Merge Diagnostics Biz into Avant Diagnostics 1/19/2016 8:35:55 AM
Amarantus BioSciences, Inc. Requests Rare Pediatric Disease And Orphan Drug Designations From US FDA For Engineered Skin Substitute In The Treatment Of Giant Congenital Melanocytic Nevi 12/29/2015 7:05:59 AM
Amarantus BioSciences, Inc. Announces Issuance Of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment Of Parkinson’s Disease And Alzheimer’s Disease 10/29/2015 12:11:54 PM
Amarantus BioSciences, Inc. Release: Past President Of The American Burn Association Dr. David Ahrenholz Provides Video Interview On Potential Of ESS For Treatment Of Severe Burns 10/14/2015 3:46:01 PM
Amarantus BioSciences, Inc. To Present At The 2015 Aegis Growth Conference 10/5/2015 3:21:55 PM
Amarantus BioSciences, Inc. To Focus Near-Term Development Efforts On Engineered Skin Substitute For Indications In Rare Pediatric Diseases 10/1/2015 8:12:50 AM